UnivIS
Informationssystem der Friedrich-Alexander-Universität Erlangen-Nürnberg © Config eG 
FAU Logo
  Sammlung/Stundenplan    Modulbelegung Home  |  Rechtliches  |  Kontakt  |  Hilfe    
Suche:      Semester:   
 
 Darstellung
 
Druckansicht

 
 
Modulbeschreibung (PDF)

 
 
 Außerdem im UnivIS
 
Vorlesungs- und Modulverzeichnis nach Studiengängen

 
 
Veranstaltungskalender

Stellenangebote

Möbel-/Rechnerbörse

 
 
Vorlesungsverzeichnis >> Naturwissenschaftliche Fakultät (Nat) >>

Drug discovery (MSM-life)30 ECTS
(englische Bezeichnung: Drug discovery)

Modulverantwortliche/r: Peter Gmeiner
Lehrende: Markus Heinrich, Christian Koch, Harald Hübner, Tim Clark, Kristina Friedland, Harald Lanig, Frank Beierlein, Norbert Jux, Andreas Burkovski, Nicolai Burzlaff, Yves Muller, Jutta Eichler, Ruth Stadler, Stefan Löber, Jürgen Einsiedel, Assistenten, Ivana Ivanovic-Burmazovic, Jürgen Schatz, Thomas Winkler, Wolfgang Kreis, Peter Gmeiner, Lars Nitschke


Startsemester: WS 2015/2016Dauer: 2 SemesterTurnus: halbjährlich (WS+SS)
Präsenzzeit: 450 Std.Eigenstudium: 450 Std.Sprache: Englisch

Lehrveranstaltungen:

  • Mandatory courses: Seminars:
    Drug Discovery-Seminar (7SEM)
    Drug Discovery-Laboratory course (23LAB),
    10 week block lab project in one of the participating research groups (see 4.)
    with
    Seminar Research projects (1S): oral presentation (20 min, plus discussion)
    Seminar Journal club (group seminar in one of the re- search groups)(2S)

    • Drug Discovery Praktikum (WS 2015/2016)
      (Praktikum, 23 SWS, Tim Clark et al., Zeit und Raum n.V.)
    • Drug Discovery Seminar (WS 2015/2016)
      (Seminar, 7 SWS, Andreas Burkovski et al., Mo, Di, 14:15 - 16:00, H Inst. Pharm. u. LmCh; Start/Beginn (Introduction/Einführungsveranstaltung): 19.10.2015 ; 14.15 Uhr . Please join on StudOn: Drug Discovery winterterm 2015/16 and summerterm 2016)
    • Drug Discovery Praktikum (SS 2016)
      (Praktikum, 23 SWS, Tim Clark et al., Zeit und Raum n.V.)
    • Drug Discovery Seminar (SS 2016)
      (Seminar, 7 SWS, Andreas Burkovski et al., Mo, 14:00 - 16:00, H Inst. Pharm. u. LmCh; Di, 14:30 - 16:00, H Inst. Pharm. u. LmCh; Mi, 17:00 - 19:00, H Inst. Pharm. u. LmCh; Einzeltermine am 18.7.2016, 19.7.2016, 8:00 - 18:00, C4 - Kleiner Hörsaal - Chemikum; Start: 12.4.2016; Presentation of Projects: 18th and 19th of july 2016)

Empfohlene Voraussetzungen:

Admission to the M. Sc. program Molecular Science or Chemistry

Inhalt:

Drug Discovery-SEMINAR
Genomics, transcriptomics, proteomics; in-vitro assay systems, assay technology; target screening and drug production in plants, drug screening and production in yeast; experimental structural biology; chemoinformatics; molecular modeling: molecular dynamics simulation, force-fields, modeling of proteins, proteinligand docking; drug synthesis and combinatorial chemistry; redox-active metal complexes, metalloenzyme inhibitors; stereochemistry in drug design; organic reactions in medicinal chemistry; drug metabolism; peptidomimetics;
LAB Course
Project course: Lab projects focusing on the modern research issues in one of the participating research groups. Seminar research projects: students reports on lab projects. Discussions on recent publications in the field of drug discovery (within the respective research units).

Lernziele und Kompetenzen:

The students are able

  • to understand the basic and advanced principles of medicinal chemical, molecular biological and computer

  • chemistry based applications in the field of modern drug design research

  • to utilize modern experimental techniques to prepare and characterize various samples with in the lab project

  • to apply modern simulation techniques for the modeling of proteins

  • to interpret and to critically summarize experimental results in written form (lab report), and to present and discuss these results within the research group or in front of a student audience

  • to participate in planning, developing and executing of experimental routes for the synthesis of drugs

  • to judge and to discuss in oral form their research results in the field of drug discovery in comparison to recent publications.

Literatur:

Manuscripts are available on StudON,
additional reading, e.g. G. Klebe, Drug Design: Methodology, Concepts, and Mode-of-Action, Springer 2013

Bemerkung:

Courses of study for which the module is acceptable: M.Sc. Molecular Lifescience

Organisatorisches:

Intended stage in the degree course: Mandatory module for M.Sc. Molecular Lifescience semester 1. and 2.
Frequency of offer: Annually / start of studies is strongly recommended in winter term
Workload: 900 hours (includes 450 hours private studies and 50 contact hours)


Verwendbarkeit des Moduls / Einpassung in den Musterstudienplan:
Das Modul ist im Kontext der folgenden Studienfächer/Vertiefungsrichtungen verwendbar:

  1. Molecular Science (Master of Science)
    (Po-Vers. 2013 | Pflichtmodul Molecular Science)

Studien-/Prüfungsleistungen:

Drug Discovery (Prüfungsnummer: 30702)

(englischer Titel: Drug Discovery)

Prüfungsleistung, mündliche Prüfung, Dauer (in Minuten): 45, benotet
Anteil an der Berechnung der Modulnote: 100.0 %
weitere Erläuterungen:
Assessment and examinations Portfolio: PL Oral examination (O 45min, 3 examiners) LEC (PL) LAB (PL, AP) Lab course protocol (without explicite mark) + oral presentation of research project (20 min + discussion);

Calculation of the grade for the module: PL: O45 (66 %) LEC (PL) (17 %) LAB (PL, AP) (17 %)

Prüfungssprache: Englisch

Erstablegung: SS 2016, 1. Wdh.: WS 2016/2017
1. Prüfer: Peter Gmeiner
1. Prüfer: Jürgen Schatz
1. Prüfer: Jutta Eichler
1. Prüfer: Markus Heinrich
1. Prüfer: Kristina Friedland

UnivIS ist ein Produkt der Config eG, Buckenhof